Applied Biosystems Expands Line Of Taqman® Microrna Assays

Today at the 2006 Annual Meeting of the American Association for Cancer Research, Applied Biosystems (NYSE:ABI), an Applera Corporation business, announced the commercial availability of 300 individual TaqMan® MicroRNA Assays (also known as miRNA assays) for human, mouse, and rat studies.

MORE ON THIS TOPIC